|
Soler-Espejo E., Chen Y., Rivera-Caravaca J.M., Ramos-Bratos M.P., Marín F., Roldán V., Lip G.Y.H. Atherogenic Index of Plasma and Residual Risk in Anticoagulated Patients With Atrial Fibrillation: The Prospective Murcia Atrial Fibrillation Project III Cohort. Journal of the American Heart Association. 2026. 15:1-12. 10.1161/JAHA.125.046694
AÑO: 2026; IF: 5.3
|
41804922
|
Soler-Espejo E., Ramos-Bratos M.P., González-Bermúdez I., Rivera-Caravaca J.M., Domínguez-Erquicia P., Íñiguez-Romo A., Marín F., Roldán V., Raposeiras-Roubín S. Impact of seasonal temperature variations on adverse outcomes in atrial fibrillation: comparative insights from Vigo and Murcia cohorts. Journal of Global Health. 2026. 16. 10.7189/jogh.16.04110
AÑO: 2026; IF: 4.3
|
|
Lopez-Galvez R, Rivera-Caravaca JM, Mandaglio-Collados D, Ruiz-Alcaraz AJ, Lahoz-Tornos A, Hernandez-Romero D, Orenes-Pinero E, Ramos-Bratos MP, Martinez CM, Carpes M, Arribas-Leal JM, Canovas S, Lip GYH, Marin F. Endothelial activation, cell-cell interactions, and inflammatory pathways in postoperative atrial fibrillation following cardiac surgery. Biomed J. 2025 Aug;48(4):100821. doi: 10.1016/j.bj.2024.100821. Epub 2024 Nov 26. PubMed PMID: 39603594; PubMed Central PMCID: PMC12332205.
AÑO: 2025; IF: 4.4
|
|
Soler-Espejo E, Chen Y, Rivera-Caravaca JM, Ramos-Bratos MP, Esteve-Pastor MA, Marin F, Roldan V, Lip GYH. Relation of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio to residual risk in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF Project III cohort. Cardiovasc Diabetol. 2025 Sep 30;24(1):374. doi: 10.1186/s12933-025-02927-x. PubMed PMID: 41029349; PubMed Central PMCID: PMC12486827.
AÑO: 2025; IF: 10.6
|
|
Mandaglio-Collados D, Ruiz-Alcaraz AJ, Rivera-Caravaca JM, Ramos-Bratos MP, Marin F, Lopez-Galvez R. Analysis of key proinflammatory mechanisms in cardiovascular pathology through stimulation with lipopolysaccharide and urban particulate matter in mouse atrial cardiomyocytes. Environ Toxicol Pharmacol. 2025 Feb 9;114:104652. doi: 10.1016/j.etap.2025.104652. Online ahead of print. PubMed PMID: 39933631.
AÑO: 2025; IF: 4.2
|